Joanne Kotz has been named CEO of Jnana Therapeutics. Kotz, a co-founder of Jnana, had been president of the company since last December, when it raised $50 million in Series A financing. Jnana is researching drugs that target solute carrier transporters, proteins that move substances across cellular membranes.
UNDERWRITERS AND PARTNERS